Genetic factors significantly influence susceptibility for substance abuse and mood disorders. Rodent studies have begun to elucidate a role of Ca v 1.3 L-type Ca 2+ channels in neuropsychiatric-related behaviors, such as addictive and depressive-like behaviors. Human studies have also linked the CACNA1D gene, which codes for the Ca v 1.3 protein, with bipolar disorder. However, the neurocircuitry and the molecular mechanisms underlying the role of Ca v 1.3 in neuropsychiatric phenotypes are not well established. In the present study, we directly manipulated Ca v 1.3 channels in Ca v 1.2 dihydropyridine insensitive mutant mice and found that ventral tegmental area (VTA) Ca v 1.3 channels mediate cocaine-related and depressive-like behavior through a common nucleus accumbens (NAc) shell calcium-permeable α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (CP-AMPAR) mechanism that requires GluA1 phosphorylation at S831. Selective activation of VTA Ca v 1.3 with (± )-BayK-8644 (BayK) enhanced cocaine conditioned place preference and cocaine psychomotor activity while inducing depressive-like behavior, an effect not observed in S831A phospho-mutant mice. Infusion of the CP-AMPAR-specific blocker Naspm into the NAc shell reversed the cocaine and depressive-like phenotypes. In addition, activation of VTA Ca v 1.3 channels resulted in social behavioral deficits. In contrast to the cocaine-and depression-related phenotypes, GluA1/A2 AMPARs in the NAc core mediated social deficits, independent of S831-GluA1 phosphorylation. Using a candidate gene analysis approach, we also identified single-nucleotide polymorphisms in the CACNA1D gene associated with cocaine dependence in human subjects. Together, our findings reveal novel, overlapping mechanisms through which VTA Ca v 1.3 mediates cocaine-related, depressive-like and social phenotypes, suggesting that Ca v 1.3 may serve as a target for the treatment of neuropsychiatric symptoms.
INTRODUCTION
Altered reward brain circuitry and reward processing is associated with multiple psychiatric disorders. 1 In particular, substance abuse disorders are often comorbid with mood disorders, particularly bipolar disorder (BD) 2 and major depressive disorder. 3 Common genetic risk factors, [4] [5] overlapping neurocircuitry 6, 7 and convergence of cellular and molecular mechanisms 7, 8 have been suggested to underlie this comorbidity. In particular, recent findings provide evidence that human variants in the CACNA1D gene, which codes for the Ca v 1.3 subunit of L-type Ca 2+ channels (LTCCs), can confer risk for the development of neuropsychiatric disorders, 9, 10 including BD. 11, 12 Emerging data on impact of human mutations on Ca v 1.3 physiology 13 and from animal studies [14] [15] [16] suggests that enhanced Ca v 1.3 activity may contribute to neuropsychiatric disorders. This is in agreement with a crucial role of this channel in neuronal signaling 10, 17, 18 underlying drug taking and emotional behaviors. However, as for the other risk genes, the precise Ca v 1.3-dependent mechanisms and neurocircuits that contribute to the neurobiology of neuropsychiatric-related behavioral phenotypes remain unknown.
The ventral tegmental area (VTA)-nucleus accumbens (NAc) pathway has a central role in mediating the effects of cocaine 19 and depressive-like 20, 21 and social behaviors. 22 LTCCs in the VTA regulate dopamine (DA) burst firing activity, 23, 24 a property known to mediate reward behaviors, 25 depressive-like behaviors, 26 social interaction 22 and responses to stress. 20, 21 We and others have shown that Ca v 1.3, which is expressed in VTA DA neurons, 27, 28 is required for the short-and the long-term effects of cocaine. [14] [15] [16] Acute activation of Ca v 1.3 by systemic injection of BayK has also been shown to induce depressive-like behavior. 28 Collectively, these findings suggest a role of Ca v 1.3 channels in addictive behavior and mood disorders.
Emerging evidence is establishing neuropsychiatric disorders as synaptic diseases. Several studies have reported enhanced glutamatergic α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) transmission, in particular, increase in synaptic GluA2-lacking Ca 2+ permeable AMPARs (CP-AMPARs herein) in medium spiny neurons of the NAc, as a key mechanism underlying cocaine-induced long-lasting behavioral plasticity. [29] [30] [31] [32] [33] [34] [35] Enhanced AMPAR transmission in the NAc has also been reported to drive depressive-like and social behavior, 36 suggesting that modulation of AMPAR transmission could represent one common mechanism linking addiction and mood disorders.
Given the evidence of enhanced VTA-NAc activity in drug taking and mood-related behaviors, 19, 21, 22 Ca v 1.3 channel properties in VTA DA cells 24 and Ca v 1.3 gain-of-function mutations in neurological disease, 10 we hypothesized that enhanced activity of VTA Ca v 1.3 channels would drive cocaine-related behaviors and mood-related phenotypes, such as depressive-like, anxiety-like and social behaviors. To this end, we utilized Ca v 1.2 dihydropyridine (DHP) insensitive (Ca v 1.2 DHP − / − ) mutant mice. A single-point mutation in the Ca v 1.2 α1 subunit of these mice e 1 does not affect Ca v 1.2 function and expression but renders them insensitive to ( ± )-BayK-8644 and strongly reduces their sensitivity to DHP Ca 2+ channel blockers, such as nifedipine. 28, 37 As successfully demonstrated in previous studies, 15, 38 this allows us to specifically pharmacologically manipulate Ca v 1.3 channels in the VTA in these mice. Subsequently, we pharmacologically assessed AMPARs in the NAc and utilized AMPAR subunit GluA1 phosphorylation-deficient mutant mice to assess the necessity of GluA1 phosphorylation in cocaine and mood-related behaviors. Finally, we tested genetic variants within and around CACNA1D for association with cocaine dependence (CD; as defined by Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria) using a genome-wide association data set.
MATERIALS AND METHODS
Detailed methods are provided in Supplementary Information.
Animals
All experimental procedures were conducted in accordance with Weill Cornell Medicine IACUC guidelines. Male C57BL/6 (Jackson Laboratories, Bar Harbor, ME, USA), Ca v 1.3 knockout (KO), 39 Ca v 1.2 DHP-insensitive 28 and GluA1 S831A phospho-mutant mice, 40 all on C57BL/6J background, were 8-10 weeks old at the start of the experiments. Animals were maintained on a 12-h light/dark cycle (from 0700 to 1900 hours).
Drugs and antibodies
Cocaine HCl, nifedipine (Nif), ( ± )-BayK-8644 (BayK) and Naspm were obtained from Sigma (St Louis, MO, USA). NBQX was obtained from Tocris Bioscience (Minneapolis, MN, USA). Nif and BayK were dissolved in 0.9% saline containing 1.5% dimethyl sulfoxide and 1.5% Tween80. Naspm and NBQX were dissolved in 0.9% saline. Antibodies are listed in Supplementary Table S1 .
Subcellular fractionation
Mice were killed by rapid decapitation and bilateral VTA (18-gauge stainless-steel stylet), NAc (18-gauge stainless-steel stylet) or prefrontal cortex (17-gauge stainless-steel stylet) tissue was obtained. Total protein lysates were isolated as previously described. 41 For postsynaptic density (PSD) fractions, subcellular fractionation was performed as published before. 42 
Coimmunoprecipiation assay
Crude membrane fractions were generated from bilateral VTA tissue pooled from four mice. Coimunoprecipitation was performed as published in Calin-Jageman et al. 43 
Immunoblot analysis
Immunoblotting and quantitation was performed as previously described in Schierberl et al. 15 Tubulin was used as a loading control for all PSD immunoblots.
Guide cannula surgery
For delivery of pharmacological drugs into the VTA or NAc, guide cannula were implanted bilaterally in adult male mice as previously published. 15 Coordinates and drug concentrations are included in Supplementary  Table S2 .
Delivery of viral vectors into the VTA or NAc
Adeno-associated viral stereotaxic surgery and delivery of the adenoassociated virus ( Supplementary Table S3 ) was performed as previously published. 15 Cocaine conditioned place preference test A three-chamber place preference protocol (Med Associates, St Albans, VT, USA) was used as previously described in Tropea et al. 44 On Day 1, mice were allowed to freely explore all three chambers (20 min). On Days 2-4 (conditioning sessions), a biased procedure was used wherein mice were paired with cocaine (10 mg kg −1 , intraperitoneal) for 20 min in the morning on the less preferred side and paired with saline for 20 min in the afternoon on the opposite side. On Day 5 (WD1), mice were allow to freely explore the conditioned place preference (CPP) box for 20 min and time spent in cocaine-paired side (s) was recorded. For some experiments, mice were re-tested on Day 34 (WD30).
Sucrose preference test
Individually housed mice were habituated to two 50-ml bottles, one containing water and the other 1% sucrose for 1 day. For 2 days, body weight and mass of water and sucrose consumed was monitored. Results are presented as sucrose preference calculated as (sucrose consumed (g)/ (sucrose consumed (g)+water consumed (g))) × 100.
Forced swim test
Mice were placed in a 2-liter beaker filled with 1600 ml of water between 25 and 26°C for 10 min. Immobility time was scored using the 
Three-chambered social interaction test
Social approach was performed as published in Inan et al. 45 Following a 10 min habituation, mice were allowed to freely explore the apparatus containing an inanimate object and a stranger mouse and time spent within a predefined contact zone was recorded.
Elevated plus maze test
Elevated plus maze (EPM) test was performed as previously reported by Lee et al. 46 
Human genetics
To examine whether genetic variants within and around CACNA1D contribute to CD susceptibility in humans, we conducted a candidate gene association analysis for CACNA1D with CD using a genome-wide association study (GWAS) data set from the Study of Addiction: Genetics and Environment (SAGE), previously described in detail 47 and as detailed in Supplementary Methods.
Statistical analyses
All statistical analyses were conducted using Graphpad Prism 6 (GraphPad Software, La Jolla, CA, USA). A two-tailed unpaired t-test was performed after confirmation of normal distribution of the data using the Shapiro-Wilk test. If data were not normally distributed, the Mann-Whitney 
RESULTS
Ca v 1.3 forms functional channels at the VTA PSD Ca v 1.3 mRNA is highly expressed in rat VTA DA neurons. 27 Ca v 1.3 protein is enriched in PSD fractions prepared from mouse VTA ( Figure 1a ) and associates with the PDZ scaffolding protein PSD-95 and Shank3 (Figures 1b and c ). This interaction through its C-terminal class I PDZ-binding domain (ITTL) is necessary for activity-dependent signaling in VTA slices, as revealed by lack of phosphorylation of the transcription factor cAMP response element-binding protein (CREB), a downstream target of Ca v 1.3 channels, 38 in the presence of a dominant-negative peptide to ITTL (Figure 1d ). Thus Ca v 1.3 protein is present in functional signaling complexes in the mouse VTA.
VTA Ca v 1.3 channel activation enhances cocaine-related behaviors
We have reported that blocking VTA Ca v 1.3 channels with nifedipine blocks cocaine psychomotor sensitization. 15 VTA Ca v 1.3 channels are necessary for a GluA1 S831 phosphorylation-dependent increase in CP-AMPARs in the NAc shell Increase in synaptic AMPAR transmission by redistribution of AMPAR subunits GluA1 and GluA2 has been observed in the NAc following cocaine treatment and behaviors. 33 We measured the levels of GluA1 and GluA2 in PSD fractions, indicative of synaptic levels, from NAc (shell and core combined) at WD1 and WD30 and role of VTA Ca v 1.3 channels therein (Figure 2a ). Cocaine CPP increased the PSD GluA1 but not GluA2 levels in the NAc at WD30 (Figure 2b ) but not at WD1 ( Supplementary Figures S2c and d) . The GluA1 increase was blocked in VTA nifedipine ( Figure 2b ) and VTA Ca v 1.3 shRNA (Supplementary Figure S2a ) pretreated mice. Cocaine had no effect on the PSD GluA1 levels in the prefrontal cortex, a region that also receives VTA projections (Figures 2a, c and Supplementary Figure S2b ).
The increase in GluA1 and not in GluA2 at WD30 suggested the possibility of accumulation of GluA2-lacking CP-AMPARs. Thus we infused the CP-AMPAR blocker, Naspm into the NAc shell 20 min before the WD30 CPP test (Figures 2d and e ) and observed an attenuation of cocaine CPP (Figure 2f ). Similarly, Naspm in the NAc shell blocked the expression of cocaine psychomotor sensitization on WD30 (Figure 2g ). Thus, cocaine results in upregulation of CP-AMPARs within the NAc shell following extended withdrawal, an adaptation that requires activation of VTA Ca v 1.3 channels.
As GluA1 synaptic function and trafficking is regulated by phosphorylation at Ser 831 (S831) via CaMKinase IIα (CaMKIIα), and Ser 845 (S845) via Protein Kinase A, 48 we measured the levels of these proteins in NAc PSD fractions at WD30. Cocaine-treated mice had higher CaMKIIα, P-CaMKIIα and P-S831 GluA1, an effect that was absent in VTA nifedipine-pretreated mice (Figure 2h ). No differences in the levels of S845 or Protein Kinase A were seen (Figure 2h ). To test the causal role of S831-GluA1 phosphorylation in inducing the cocaine behaviors, we utilized S831 phosphorylation-deficient mutant mice (S831A). 40 Wild-type and S831A mice exhibited similar levels of cocaine preference at WD1 ( Figure 2i ) and similar psychomotor sensitization on cocaine Day 5 ( Figure 2j ). However, at WD30, S831A mice had a blunted CPP response ( Figure 2i ) and a blunted psychomotor response ( Figure 2j ). Collectively, the above experiments demonstrated that activation of VTA Ca v 1.3 channels are necessary for mediating the protracted accumulation of CP-AMPARs in the NAc shell via upregulation of CaMKIIα and S831-GluA1 phosphorylation. 
Activation of Ca v 1.3 channels in the VTA promotes depressive-like behavior and cocaine-related behavior and induces deficits in social behavior
To determine whether VTA Ca v 1.3 channel manipulation is sufficient to alter mood-related and social behaviors, we used a repeated Ca v 1.3 channel activation protocol (BayK, once a day for 3 days, Figure 3a ) in the VTA of Ca v 1.2 DHP − / − mice, which has previously been shown to induce long-term behavioral changes in response to cocaine. 14 Repeated VTA-BayK infusion induced anhedonia in the sucrose preference test (SPT) and increased immobility in the forced swim test (FST), when tested 30 days after the last BayK infusion (Figures 3b and c) . In a separate cohort, we also observed that BayK effects emerged as early as 24 h after the last BayK infusion ( Supplementary Figures S3a and b) . VTA-BayK treatment also decreased social approach behavior in the threechamber social interaction test (Figure 3d and Supplementary Figure S3c ). As previously reported, 14 VTA-BayK also potentiated cocaine-induced locomotor activity when measured 30 days after the last BayK infusion (Supplementary Figure S3g) but not 24 h later (Supplementary Figure S3d) . VTA-BayK infusions had no effect on anxiety-like behavior or basal locomotor activity at either time point ( Supplementary Figures S3e, f, h and i) . Of note, repeated systemic BayK administration in Ca v 1.2 DHP − / − mice had a similar effect on SPT, FST, social and cocaine-related behaviors, with no effect on EPM and basal locomotor activity ( Supplementary Figures S3j-o) .
Thus activation of Ca v 1.3 channels in the VTA is sufficient to induce mood-related and cocaine behaviors that are long lasting.
In contrast to VTA Ca v 1.3 activation, inhibition of Ca v 1.3 with repeated nifedipine had no effect on depressive-like, social or cocaine-induced locomotion when measured 24 h after the last nifedipine infusion ( Supplementary Figures S4a-d) and had a milder effect 30 days later ( Supplementary Figures S4g-j ) with no effect on anxiety-like behavior or basal locomotion ( Supplementary  Figures S4e, f, k, and l) .
CP-AMPARs in the NAc shell mediate BayK-induced cocaine and depressive-like behavior
Formation of CP-AMPARs in the NAc has been reported in models of chronic stress 36 and chronic neuropathic pain-induced depressivelike behaviors. 49 Thus we measured the levels of GluA1 and GluA2 in NAc (shell and core) PSD fractions 30 days following VTA-BayK infusions and both were higher in BayK-infused mice (Figure 3e ). Interestingly, even though BayK induced depressive-like and social behavioral deficits 24 h after the last BayK administration, neither GluA1 nor GluA2 were significantly altered at 24 h (Supplementary Figure S5a) . To test the potential role of CP-AMPARs in VTA BayKinduced behaviors at the 30-day time point, given overlapping mechanisms, 8 Naspm was administered into the NAc shell 30 min prior to behavioral testing (Figure 3f ), a manipulation that blocked VTA BayK-induced decrease in SPT (Figure 3g ) and increase in immobility during FST (Figure 3h ; no effect on vehicle-treated mice). Naspm additionally attenuated enhanced cocaine-induced locomotor activity in BayK-treated mice (Figure 3i ). Interestingly, Naspm in the NAc shell had no effect on social approach behavior ( Figure 3j ) nor in the NAc core (Figure 3k ), whereas blocking GluA1/A2 AMPARs with NBQX in the NAc core (Figure 3l and Supplementary Figure S5b) but not in the NAc shell (Figure 3m ) reversed the deficit in social approach. Thus long-term effect of repeated VTA-BayK on depressive behavior results from increase in CP-AMPARs in the NAc shell, whereas its effect on social behavior results from increase in GluA1/ A2 AMPARs in the NAc core. Next, we tested whether repeated VTA-BayK alters protein kinase and GluA1 phosphorylation levels in the NAc. Similar to cocaine exposure (Figure 2h ), we found that VTA-BayK infusion increased the levels of NAc CaMKIIα and P-S831-GluA1 30 days following BayK infusion (Figure 4a ). To test the causal role of S831-GluA1 phosphorylation on behaviors, we utilized S831A-GluA1 phospho-mutant mice. At baseline, S831A did not differ from wild-type mice in the SPT (Supplementary Figure S6a) , FST (Supplementary Figure S6b) , social behavior (Supplementary Figure S6c) , EPM (Supplementary Figure S6d) or basal locomotor activity (Supplementary Figure S6e) . In contrast, VTA BayK-induced anhedonia (Figure 4b ), increased immobility ( Figure 4c ) and enhanced cocaine-induced locomotor activity (Figure 4e) were not observed in S831A mice. Interestingly, wild-type and mutant mice exhibited similar social approach behavior (Figure 4d) , demonstrating a causal role of S831-GluA1 phosphorylation in the NAc for VTA BayK-induced depressive-like and cocaine-related behaviors, but not social behavior. VTA-BayK infusions had no effect on anxiety-like behavior or basal locomotor activity in either genotype ( Supplementary Figures S6f and g) .
Significant association of CACNA1D SNPs with CD Based on our findings of a role for Ca v 1.3 channels in rodent cocaine behaviors, we tested whether variants within and around CACNA1D were associated with CD using the GWAS (GWAS data set from the SAGE). To examine as many variants as possible, we imputed the 1000 Genomes Project variants into CACNA1D. Specifically, we tested 947 single-nucleotide polymorphisms (SNPs) within and around CACNA1D in European-Americans (EA; 493 cases and 1058 controls; Supplementary Table S4 ) and followed analyses of any significant findings in African-Americans (AA; 521 cases and 369 controls; Supplementary Table S4 ). We performed an association test in a logistic regression framework including sex, age and top three principle components as covariates. We found the strongest association with CD for intronic SNP rs4687735 in EAs (P = 1.3 × 10 − 5 , odds ratio (OR) = 2.46, 95% confidence interval (CI) = 1.65-3.67), an imputed intronic SNP (imputation quality score = 0.82) with a risk allele 'T' frequency of 6.5% in cases and 3.5% in controls, which remains significant after Bonferroni's correction (P = 0.012). In addition, another two imputed SNPs, rs2926559 and rs898407, which are in high linkage disequilibrium with rs4687735, also showed strong association with CD (rs2926559, P = 0.018 and rs898407, P = 0.019 after Bonferroni's correction). Figure 5 illustrates the association test results for 947 SNPs within and around CACNA1D in EAs.
We observed a trend association in the same direction as in EAs for rs4687735 in AAs (P = 0.14, OR = 2.62, 95% CI = 0.68-10.15), with risk allele 'T' frequency of 1.1% in cases and 0.45% in controls (imputation quality score = 0.88). Meta-analysis of the EA and AA samples showed stronger association between rs4687735 and CD (P = 4.0 × 10 − 6 , OR = 2.47, 95% CI = 1.68-3.63). We also observed trend associations for the rs2926559 (P = 0.13, OR = 2.42, 95% CI = 0.72-8.07) and rs898407 (P = 0.14, OR = 2.51, 95% CI = 0.68-9.23) in AAs. Supplementary Table S5 shows association results for EAs and AAs and meta-analysis for 778 SNPs that exist in both EAs and AAs.
To evaluate the association evidence at the gene level, we further computed a gene-based P-value for the EA and AA samples using GATES, a gene-based association test using extended Simes procedure. 50 We found significant association evidence in both EA (P = 0.003) and AA (P = 0.008). 
DISCUSSION
Here we demonstrate that VTA Ca v 1.3 channel activation robustly mediates cocaine-related, depression-related and social behaviors via distinct NAc AMPAR mechanisms with no effect on anxiety-like behavior. These findings provide novel insight into VTA Ca v 1.3 to NAc mechanisms that likely underlie behavioral phenotypes in multiple neuropsychiatric illnesses. We propose that Ca v 1.3 activation may mediate comorbid phenotypes in addiction and mood disorders. Our identification of CACNA1D SNPs associated with CD, in combination with previous human genetic data linking CACNA1D with BD, 11, 12 suggests a potential role for VTA CACNA1D in mediating comorbid behavioral endophenotypes in addiction and BD. The data also support further investigation of Ca v 1.3 as a potential therapeutic target for neuropsychiatric disorders with substance abuse, depression or social deficit-related phenotypes.
The current findings add to the emerging evidence for convergent mesolimbic DA pathway mechanisms mediating behavioral deficits in reward-related and mood disorders. 2, 7, 51 We believe our study is the first to examine Ca v 1.3 mechanisms across drug-related, depression-related and social-related behaviors and the first to link Ca v 1.3 animal studies to human GWAS data. The ability of VTA Ca v 1.3 activation to enhance cocaine behaviors after extended withdrawal is consistent with previous demonstration of VTA LTCCs activation potentiating cocaine-induced psychomotor response 14 and with a critical role of VTA Ca v 1.3 LTCCs in cocaine behaviors. 15, 16 The observed depressive-like effects of VTA Ca v 1.3 activation are consistent with our previous demonstration where global Ca v 1.3 activation resulted in depressive-like behavior, 28 while Ca v 1.3 − / − mice showed an antidepressant-like response. 52 We additionally show for the first time that VTA Ca v 1.3 channel activation results in social behavioral deficits. The novelty of the present finding is our identification of the VTA as a critical brain locus mediating these Ca v 1.3-dependent depressive-like and social behavioral phenotypes in parallel with cocaine-induced phenotypes. Thus we demonstrate for the first time that enhancing VTA Ca v 1.3 activation is a common mechanism that can induce behavioral alterations associated with substance abuse and mood-related psychiatric illnesses. Indeed, multiple investigations over the past several years have begun to elucidate specific VTA mechanisms that are activated by stress and by drugs of abuse. 6, 8, 51 Importantly, our findings provide novel pathway-specific molecular insights regarding the mechanisms underlying these reward, mood and social interaction-related behaviors. Our data show that activation of VTA Ca v 1.3 channels is sufficient to increase CP-AMPARs in the NAc shell; their activation, in turn, is necessary for cocaine CPP and enhanced locomotor response measured after 41 month, but not 1 day, of withdrawal. These findings are generally consistent with a role for cocaine-evoked CP-AMPARs in the NAc shell in certain models of addictive behavior, although most such evidence has been obtained after cocaine self-administration. [31] [32] [33] [34] [35] [53] [54] [55] Cocaine-evoked CP-AMPARs in NAc core also mediate cocaine seeking after cocaine selfadministration and prolonged withdrawal. 30, [54] [55] [56] It will be interesting in future studies to further examine NAc core vs shell AMPAR mechanisms in the model used in this study.
We further demonstrate that similar to cocaine, VTA Ca v 1.3induced depressive-like behavior results from increase in CP-AMPARs in the NAc shell. Although the role of CP-AMPARs in depressive-like behavior has not been clearly delineated in the literature, recent studies have revealed changes in CP-AMPAR expression that are associated with exposure to a stress protocol that induces anhedonia. 36 Vialou et al. 57 also showed that mice susceptible to social defeat stress show higher levels of GluA1 expression in the NAc, with no change in GluA2 suggestive of an increase in CP-AMPARs. Additionally, CP-AMPARs in the NAc have been found to emerge in a chronic neuropathic pain-induced depression model. 49 Collectively, these studies support the conclusion that VTA Ca v 1.3 activation promotes cocaine and depressive-like behavior via enhancing synaptic CP-AMPARs. One mechanism suggested to contribute to increases in CP-AMPAR levels at the synapse is S831-GluA1 phosphorylation by CaMKIIα. 48 We demonstrate the necessity of S831-GluA1 phosphorylation for VTA Ca v 1.3-mediated enhancement of cocaine and depressive-like behaviors, highlighting VTA Ca v 1.3 mechanistic convergence. The ability of VTA Ca v 1.3 activation to increase NAc CaMKIIα activity also argues for a converging CaMKIIα mechanism. Previous studies have found an increase in CaMKIIα in the NAc of rats following 14 days of withdrawal from non-contingent cocaine administration 58 and in the NAc of cocaine-dependent humans, 58 as well as following social defeat stress. 59 Additionally, a SNP in the CaMK2A gene has been linked to faster transition to severe cocaine use in humans. 60 A direct link between CaMKIIα and formation of CP-AMPARs remains to be established; however, concurrent increase in phosphorylated CaMKII and CP-AMPARs at the NAc PSD following extended withdrawal from cocaine selfadministration has been observed. 61 We additionally demonstrate that activation of VTA Ca v 1.3 channels also promotes social deficits, however, via enhancing GluA1/A2 AMPARs in the NAc consistent with enhanced AMPAR transmission associated with social deficits, 62 including in the NAc core. 63 To the best of our knowledge, this is the first time that Ca v 1.3 channels have been associated with social behavior. The recruitment of AMPARs in the NAc core vs CP-AMPARs in the NAc shell in our models of cocaine and depressive-like phenotypes suggests the possibility of recruitment of different VTA-NAc neurons mediating diverse behavioral phenotypes. This is not surprising given the highly heterogeneous nature of the VTA afferents to the NAc and other regions of the brain, 26, 64 a question that will be addressed in future studies. Additionally, the higher but not significant levels of S880 P-GluA2 in the PSD of NAc (core +shell) is intriguing given that this phosphorylation event has been suggested to endocytose GluA2 subunits. 65, 66 However, States et al. 67 have reported that S880 phosphorylation can stabilize GluA2 at the PSD, which could be the case in the NAc core where we find higher GluA1/GluA2 AMPARs. In future studies, it will be interesting to further explore the role of S880 GluA2 phosphorylation in GluA2 trafficking and social behavior.
The precise VTA Ca v 1.3 mechanisms that promote cocaine and depressive-like behaviors remain to be answered. Preliminary findings from our laboratory suggest that Ca v 1.3/CaMKII/ERK2 signaling within the VTA mediates long-term molecular changes in the NAc via a CREB-dependent mechanism. CREB in the VTA has been suggested to have a role in cocaine-induced plasticity, 68 an area of research that remains underexplored. One potential candidate downstream of the Ca v 1.3/CREB pathway in the VTA that may mediate the transition from the VTA to NAc is the neurotrophic factor brain-derived neutrotrophic factor (BDNF), a downstream target of LTCCs 69,70 and of CREB 71,72 that regulates both cocaine 73 and depressive-like behaviors. 74 Phasic firing of VTA DA neurons promotes cocaine 25 and depressive behaviors, 26 a DA neuron property that also facilitates BDNF release in the NAc. 8 BDNF in the NAc, via its postsynaptic TrkB receptor, regulates CaMKII-mediated S831 GluA1 phosphorylation, 75 AMPAR trafficking 76, 77 and cocaine and depressive behaviors. 73, 74, 78 Thus, BDNF produced in the VTA and released in the NAc serves as a promising candidate in mediating the effect of VTA Ca v 1.3 channels. Our unpublished data support this hypothesis as we find that VTA Ca v 1.3 channel activation increases Bdnf transcription in the VTA. Future studies will address VTA Ca v 1.3-mediated BDNF release and postsynaptic effects in the NAc on AMPAR signaling and cocaine and mood-related behaviors.
Candidate gene association analysis in humans supports the role of genetic variations within CACNA1D in CD. To the best of our knowledge, this is the first report describing a genetic association between CACNA1D and CD in two independent human samples, which corroborates the functional aspects of Ca v 1.3 in the mice models of cocaine behavior. Considering the fact that CACNA1D SNPs can confer risk for BD 11, 12 as well as the association of human CACNA1D gain-of-function mutations associated with neurological disorders, 10 including autism, 13 characterized by significant mood dysregulation, an important follow-up investigation would be to examine via targeted sequencing whether rare variants within CACNA1D are also associated with CD. Further finemapping of this gene may contribute to the identification of functional causal variants underlying CD.
In summary, findings of this study support enhanced Ca v 1.3 channel activity within the VTA-NAc pathway as one potential mechanism underlying drug abuse and mood disorders, with implications for comorbid neuropsychiatric-related behavioral phenotypes, in particular, those resulting from disease-associated CACNA1D SNPs. The study provides a novel framework to further understand the pathophysiology of mental illness that can aid in designing therapeutic studies using available Ca v 1.3-selective LTCC blockers. 79 
